Skip to content

Adolescents and Young Adults With Cancer: Their Preferred Involvement in Decision Making

Adolescents and Young Adults With Cancer: Their Preferred Involvement in Decision Making

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07035418
Enrollment
100
Registered
2025-06-25
Start date
2022-08-23
Completion date
2026-08-01
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Behavior

Keywords

Cancer, Survivor, Adolescent and Young Adults

Brief summary

The purpose of this mixed-methods study is to determine Adolescent and Young Adult (AYAs) decision making preferences post cancer diagnosis using vignettes designed to assess their preferred involvement in decisions about their cancer treatment and variables associated with these treatment decision-making (TDM) preferences.

Interventions

BEHAVIORALClinical Decision-Making Scenarios and Preferences Assessment

Participants complete a socio-demographic questionnaire and decision-making preferences scale, including hypothetical clinical scenarios, to identify their preferred decision-making role (active, collaborative, or passive) and the influence of providers or family. Delivered electronically via secure link; reminders sent as needed.

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* Age (15-29 years) * Cancer diagnosis and on therapy, end-of-life or survivors (within 1 year) * Speaks English * Reads English * Cognitively and physically able to participate

Exclusion criteria

* Unable to participate in study due to developmental delay or developmental disorder

Design outcomes

Primary

MeasureTime frameDescription
Distribution of Decision-Making Roles in Clinical ScenariosWithin 2 weeks of survey link deliveryProportion of participants who select an active, collaborative, or passive role in hypothetical clinical decision-making scenarios. Each role will be counted and compared across participant subgroups.

Secondary

MeasureTime frameDescription
Association Between Sociodemographic Characteristics and Decision-Making RoleAt time of electronic survey completionThis outcome assesses the association between sociodemographic characteristics (e.g., age, race/ethnicity, gender, education level, and employment status) and adolescents' and young adults' preferred treatment decision-making role. Role preference (active, collaborative, or passive) is assessed using the modified Control Preferences Scale. Sociodemographic variables are self-reported via electronic questionnaire. The unit of measure is the chi-square test statistic or ANOVA output, depending on the variable type.
Concordance Between Interview Responses and Scenario-Based Decision-Making RolesAt time of interview, within 4 weeks of survey completionProportion of interview responses that align with or differ from role preferences identified in hypothetical scenarios. Qualitative responses will be coded and categorized into roles for comparison.
Correlation Between Healthcare Encounters and Decision-Making Role PreferenceAt time of interview, within 4 weeks of survey completionThis outcome measures the correlation between the number of cancer-related healthcare encounters and adolescents' and young adults' preferred treatment decision-making role. Healthcare encounters will be abstracted from the electronic health record and include clinic visits, procedures, hospitalizations, ICU stays, and emergency department visits. Decision-making role preference (active, collaborative, or passive) will be assessed using the modified Control Preferences Scale. The unit of measure is the Pearson correlation coefficient.

Countries

United States

Contacts

CONTACTSwathi Alagandula
drswathi@stanford.edu650-725-1976
PRINCIPAL_INVESTIGATORKimberly Pyke-Grimm

Stanford University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026